Description
Tresiba FlexTouch (Insulin Degludec): Canada's Long-Acting Insulin Pen, Explained
If your endocrinologist has moved you onto Tresiba, you've probably already heard the pitch: one injection a day, a flatter action profile than older basal insulins, and a lot more room to breathe if your schedule isn't perfectly predictable. What most product pages skip is why that matters and how to actually use the pen without second-guessing yourself. Here's the full picture.
What Tresiba Actually Is
Tresiba's active ingredient is insulin degludec, an ultra-long-acting basal insulin developed by Novo Nordisk. It's approved by Health Canada for adults, adolescents, and children as young as one year old with type 1 or type 2 diabetes, used to manage blood glucose over 24 hours rather than covering meals the way rapid-acting insulins do.
What sets degludec apart chemically is how it behaves once injected. It forms soluble multi-hexamer chains under the skin that break apart slowly, releasing insulin into the bloodstream at a near-constant rate. That's the mechanical reason behind Tresiba's two headline features:
| Feature | Why it matters |
|---|---|
| Half-life of roughly 25 hours | Blood levels stay steady even if a dose is a few hours early or late |
| Duration beyond 42 hours | Missing the "usual" time by a wide margin still leaves insulin coverage in place |
| Steady state in 2–3 days | Once you're stable on a dose, day-to-day glucose swings from the insulin itself are minimal |
For someone comparing this to Lantus (insulin glargine U-100) or Levemir (insulin detemir), the practical difference is flexibility. Older basal insulins generally need to go in around the same time daily, give or take an hour. Tresiba's label allows for dosing flexibility when needed, which matters for shift workers, frequent travelers, or anyone whose routine isn't fixed.
FlexTouch Pen: What You're Actually Injecting With
Tresiba ships in a prefilled FlexTouch pen, available in two strengths:
- Tresiba FlexTouch U-100 — 100 units/mL, dials in 1-unit increments, up to 80 units per injection
- Tresiba FlexTouch U-200 — 200 units/mL, dials in 2-unit increments, up to 160 units per injection, in a smaller pen for higher total daily doses
The U-200 pen isn't just "double strength for convenience" — it's built for patients whose total daily basal requirement would otherwise mean carrying multiple U-100 pens. Your prescription will specify which one, and they are not interchangeable by simply adjusting the dial — always confirm you're using the strength your prescriber ordered.
Using the pen, step by step:
- Attach a new needle before each injection and prime with a 2-unit air shot until you see insulin at the needle tip.
- Dial your prescribed dose using the dose selector.
- Inject subcutaneously into the thigh, upper arm, or abdomen, rotating sites to reduce lipodystrophy.
- Hold the pen against the skin for 6 full seconds after pressing the button, to ensure the full dose clears the needle.
- Remove and safely dispose of the needle in a sharps container immediately after use.
Storage: The Part People Get Wrong
| Status | Storage | Max duration |
|---|---|---|
| Unopened pens | Refrigerated, 2–8°C | Until expiry date on carton |
| In-use pen | Room temperature, below 30°C, away from direct heat/light | 8 weeks, then discard even if insulin remains |
| Never | Frozen | Discard immediately if frozen |
An in-use pen left in the fridge is fine — many patients do this deliberately once they've dialed in their storage routine — but once a pen has been at room temperature and in active use, the 8-week clock doesn't reset by putting it back in the fridge.
Dosing Isn't One-Size-Fits-All
Your starting dose and titration schedule come from your prescriber, based on your current insulin regimen, A1C targets, and whether you're type 1 or type 2. Tresiba is typically titrated in small increments — often every few days — based on fasting glucose readings, not adjusted daily on your own initiative. If you're switching from another basal insulin, that transition is usually done under supervision, since insulin-to-insulin conversion isn't always a straight unit-for-unit swap.
Signs to contact your care team promptly:
- Repeated fasting glucose readings outside your target range
- Symptoms of hypoglycemia (shakiness, sweating, confusion) — the most common side effect with any basal insulin
- Injection site reactions that don't resolve with site rotation
- Illness, since insulin needs can shift significantly during infection or reduced appetite
Tresiba vs. Other Basal Insulins in Canada
| Status | Tresiba (degludec) | Lantus (glargine U-100) | Toujeo (glargine U-300) | Levemir (detemir) |
|---|---|---|---|---|
| Duration | 42+ hours | ~24 hours | ~24–36 hours | 18–24 hours (dose-dependent) |
| Dosing flexibility | Higher | Lower — consistent timing preferred | Moderate | Lower, sometimes twice daily |
| Onset | Gradual | Gradual | Gradual, slower than U-100 | Gradual |
| Pen strengths | U-100 / U-200 | U-100 | U-300 | U-100 |
No single basal insulin is objectively "best" — the right one depends on your glucose patterns, lifestyle, and how your body responds, which is exactly why this stays a conversation with your prescriber rather than a self-directed switch.
Why Order Tresiba Through a Canadian Pharmacy
Insulin pricing in the US has made Canadian pharmacy access a genuine lifeline for a lot of patients, and Tresiba is one of the more frequently requested transfers we see. Ordering through us means:
- A valid prescription is required and verified, the same as any Canadian or US pharmacy
- Cold-chain-appropriate, discreet shipping designed for temperature-sensitive medications like insulin
- Access to both FlexTouch strengths, so your order matches your prescription exactly
- Canadian pharmacist support if you have questions before your order ships
Is Tresiba the same as Levemir or Lantus?
No. Tresiba, Levemir, and Lantus are all long-acting basal insulins, but they contain different active ingredients: insulin degludec, insulin detemir, and insulin glargine, respectively. Their duration and dosing characteristics also differ, so they should not be switched without guidance from your prescriber.
Can I take Tresiba at a different time each day?
Tresiba offers some dosing-time flexibility when necessary. Canadian product information allows adults to change the dosing time, provided there are at least 8 hours between injections. However, maintaining a consistent daily schedule is generally preferred whenever possible.
How long does an opened Tresiba pen last?
An opened Tresiba pen can generally be used for up to 8 weeks after first use when stored according to the product instructions. After 8 weeks, discard the pen even if insulin remains.
Does Tresiba need to be refrigerated after I start using it?
No. Once in use, Tresiba can generally be stored at room temperature below 30°C or refrigerated according to the product instructions. Do not freeze insulin or expose it to excessive heat or direct sunlight.
Tresiba Insulin FlexTouch is a prescription medication and should be used only as directed by a healthcare professional. It is not intended to treat diabetic ketoacidosis. Never change your insulin dose without medical guidance. This information is for educational purposes only and does not replace professional medical advice.
Reviews
There are no reviews yet.